Our results suggest a novel role for plexin-A2 as a modulator of glioblastoma cells proliferation and indicate that inhibitors of plexin-A2/plexin-A4 may perhaps represent new targets for the development of anti-tumorigenic drugs. The gene discussed is PLXNA4; the disease is glioblastoma.